ArticleGenetics and molecular biology2026
Isoforms in action: The impact of transcript diversity in phenotype.
Article in Genetics and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study of RNA processing, in particular how alternative splicing and the use of alternative transcription start and end sites generate diverse transcript isoforms from a single gene, has advanced significantly alongside the development of RNA sequencing technologies. High-resolution whole-transcriptome sequencing has shown that much of the transcriptomic diversity observed in humans, compared to other species, stems from these alternative RNA processing events. Primary studies first revealed that a single gene could give rise to multiple RNA variants, which challenges the linear interpretation of the central dogma of molecular biology. However, progress in the field was limited by technological constraints and the inherent complexity of resolving isoforms at high resolution. Recent breakthroughs, which includes long-read sequencing, high-throughput FISH-based imaging, isoform-specific quantification tools, and improved software for transcript detection and quantification, have reignited interest and enabled a more detailed view of transcriptomic diversity. Understanding alternative isoforms is significant, as they expand the proteome, fine-tune gene regulation, and influence cellular phenotypes that are key to human disease research and possible therapeutic development.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.